Immune checkpoints, such as cytotoxic T lymphocyte-associated antigen (CTLA-4) and programmed death ligand 1 (PD-L1), inhibit the activity of T lymphocytes to identify and eliminate cancer antigens 6. This evidence concerns the gene CD274 and cancer.